Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and development.
Cooper, David A
Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and development. [electronic resource] - The Lancet. Infectious diseases Jul 2004 - 426-36 p. digital
Publication Type: Journal Article; Review
1473-3099
10.1016/S1473-3099(04)01058-8 doi
Acquired Immunodeficiency Syndrome--drug therapy
Amino Acid Sequence
Cell Fusion
Clinical Trials as Topic
Enfuvirtide
HIV Envelope Protein gp41--chemistry
HIV Fusion Inhibitors--chemistry
HIV Infections--drug therapy
HIV-1--drug effects
Humans
Peptide Fragments--chemistry
Peptides--chemistry
Virus Physiological Phenomena
Viruses--drug effects
Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and development. [electronic resource] - The Lancet. Infectious diseases Jul 2004 - 426-36 p. digital
Publication Type: Journal Article; Review
1473-3099
10.1016/S1473-3099(04)01058-8 doi
Acquired Immunodeficiency Syndrome--drug therapy
Amino Acid Sequence
Cell Fusion
Clinical Trials as Topic
Enfuvirtide
HIV Envelope Protein gp41--chemistry
HIV Fusion Inhibitors--chemistry
HIV Infections--drug therapy
HIV-1--drug effects
Humans
Peptide Fragments--chemistry
Peptides--chemistry
Virus Physiological Phenomena
Viruses--drug effects